Logtra

Atlantic Logistics currently trades on the OTC market under the symbol PRTT (Protect Pharmaceutical Corp.). A name change will be filed for in the coming months to a name more fitting of our current business model.

Previous news announcements:

Protect Pharmaceutical Corp. Announces that KARINCA Logistics Merger Will Not Proceed

Date: Sep 3, 2024

--Protect Pharmaceutical Corp. and Atlantic Logistics announce there will be no merger with KARINCA Logistics. The previous announcement on August 28, 2024, on the merger between KARINCA Logistics and PRTT should not be relied upon.. Additionally, Director George Athanasiadis has resigned from the board of directors. [read more...]


Protect Pharmaceutical Corp. (PRTT) Finalizes the Merger with KARINCA Logistics

Date: Aug 28, 2024

--Protect Pharmaceutical Corp. announces it completed the necessary documentation to finalize the merger with KARINCA Logistics- www.karincalogistics.com.. KARINCA Logistics brings a large network of operations, many very valuable routes, and opens sales opportunities throughout Europe and Asia. Ozgur Ozcan, PRTT's CEO, stated," with the merger complete we [read more...]


Protect Pharmaceutical Corp. (PRTT) Announces New CEO and New Director; Moves to Finalize the Karinca Logistics Merger

Date: Aug 15, 2024

--Protect Pharmaceutical Corp. announces the appointment of a new CEO, restructuring of the Board of Directors, and looks to finalize the merger agreement with Karinca Logistics- www.karincalogistics.com.. The Company appointed Ozgur Ozcan as CEO and Director and George Athanasiadis as Director. Ozgur Ozcan, PRTT's CEO, stated, "This is an exciting time for the [read more...]


Protect Pharmaceutical Corp. Issues Corporate Update

Date: Jul 1, 2024

--Protect Pharmaceutical Corp.' s President, Ali Yildiz, provides its shareholders with the following informational update:. We have a few items remaining that are required to be completed by the local jurisdiction of the company in Turkey. The Company has also been involved in negotiations with a potential merger/acquisition with one of the major Turkish [read more...]


Protect Pharmaceutical Corp.'s President, Ali Yildiz, Issues a Letter to Shareholders

Date: Feb 5, 2024

--Protect Pharmaceutical Corp.' s President, Ali Yildiz, publishes his February 2024 corporate update letter to Company Shareholders as follows:. The Company is drafting a Form 10 registration statement that will be filed with the SEC to resume reporting to the SEC. The audited financial statements for 2021 are expected to show that the Company had a total [read more...]


Ali Yildiz, President of Protect Pharmaceutical Corp., Issues Letter to Shareholders

Date: Jan 9, 2024

--Protect Pharmaceutical Corp.’ s President, Ali Yildiz, publishes a letter to Company Shareholders as follows:. "Dear Shareholders of Protect Pharmaceutical Corp.:. We are also proud to report that shipments to Azerbaijan have greatly increased proceeding our recent acquisition on Bosfor Export. [read more...]


Ali Yildiz December 29, 2023 Letter to the Shareholders of Protect Pharmaceutical Corp.

Date: Dec 29, 2023

--Protect Pharmaceutical Corp." OTC:" Ali Yildiz Addresses shareholders of the company.. We wanted to update shareholders in regards to the progress on our PCAOB Audit. We are preparing multiple new routes that will include South America, Eurasia, Eastern Europe and of course Turkey. [read more...]


Ali Yildiz December 22, 2023 Letter to the Shareholders of Protect Pharmaceutical Corp.

Date: Dec 22, 2023

--Protect Pharmaceutical Corp." OTC:" Ali Yildiz Addresses shareholders of the company.. As we stated last week we are in the final stages of our PCAOB audit and expect its completion very soon. We have now responded to the open items to the auditor. [read more...]


Protect Pharmaceutical Corp. CEO Provides Shareholder Update

Date: Dec 15, 2023

--Protect Pharmaceutical Corp." OTC:" Protect Pharmaceutical Corp. CEO Ali Yildiz Provides Shareholder Update.. As CEO of PRTT I wanted to update shareholders on current progress within the company. Upon finalizing the audit we will prepare and file a form 10 for the company to resume reporting with the SEC and upon the form 10 becoming effective we plan to change [read more...]


Protect Pharmaceutical Corp. Acquires Bosfor Export

Date: Nov 24, 2023

--Protect Pharmaceutical Corp." OTC: PRTT" is pleased to announce the acquisition of Bosfor Export. With this acquisition, PRTT's management is optimistic about significantly increasing revenues by leveraging Bosfor Export's valuable routes and client base, which extends from South America to Eastern Europe. In line with ongoing PCAOB audit requirements, [read more...]